Jane Lowe Meisel, MD

One star
One star
One star
One star
One half star

Rating: 4.9 out of 5 (345 ratings)

Role

Medical Oncology
Specialty

Breast Cancer
Research Program

Discovery and Developmental Therapeutics
Practicing Since

2014

Request Appointment

Background

Jane Lowe Meisel, MD, is a board certified medical oncologist with a special interest in women's health and in cancers that affect women, including breast, cervical, endometrial and ovarian cancers. Her goal is to provide compassionate, exceptional, state-of-the-art care to patients fighting these diseases, and to conduct research that improves treatment options for these patients.

Dr. Meisel is associate professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine, with a secondary appointment in the Department of Gynecology and Obstetrics. She joined the Glenn Family Breast Center at Winship Cancer Institute as a practicing physician in 2015.

Titles & Roles

Associate Professor, Department of Hematology and Medical Oncology

Emory University School of Medicine
Associate Professor, Department of Gynecology & Obstetrics

Emory University School of Medicine

Education & Training

Education

Fellowship, Medical Oncology, 2014
Memorial Sloan Kettering Cancer Center
Residency, Internal Medicine, 2011
Brigham and Women's Hospital
Medical Education, , 2008
Harvard Medical School

Board Certifications

Medical Oncology
American Board of Internal Medicine, 2014
Internal Medicine
American Board of Internal Medicine, 2011

Professional Memberships

Dr. Meisel is a member of the Eastern Cooperative Oncology Group and serves on the Development Therapeutics Committee at NRG Oncology. She also serves as leader of the Professional Development Committee Women in Oncology Work Group and as a member of the Cancer Education Committee at American Society of Clinical Oncology.

Research

Dr. Meisel has presented her research on breast cancer and gynecologic malignancies at national meetings and has published her work in peer-reviewed journals. Her research is focused on the development of new therapeutic options for women with gynecologic and breast cancers, and on improving quality of life for these patients.

Clinical Trials

Dr. Meisel serves as the principal investigator for many therapeutic trials for patients with breast and gynecologic malignancies at Winship Cancer Institute.

View Current Clinical Trials


Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab Phase III Conditions Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma Location Emory University Hospital Midtown, Emory Saint Joseph's Hospital, Winship Cancer Institute, Grady Health System
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer Phase II Conditions HER2-positive Breast Cancer, Invasive Carcinoma of the Breast, Breast Cancer, Node Negative Breast Cancer, Micrometastasis Breast Cancer, Hormone Receptor Positive Breast Cancer Location Emory University Hospital Midtown, Emory Saint Joseph's Hospital, Winship Cancer Institute
A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer Phase I Conditions Hormone Receptor Positive Breast Carcinoma, HER2-negative Breast Cancer Location Winship Cancer Institute
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer Phase I Conditions Triple Negative Breast Cancer Location Emory University Hospital Midtown, Winship Cancer Institute

Title/Journal	Authors	Publication Date
High tumor infiltrating lymphocytes are significantly associated with pathological complete response in triple negative breast cancer treated with neoadjuvant KEYNOTE-522 chemoimmunotherapy. Breast cancer research and treatment	SJ Wood, Y Gao, JH Lee, J Chen, Q Wang, JL Meisel, X Li	01/05/2024
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	EL Mayer, Y Ren, N Wagle, R Mahtani, C Ma, A DeMichele, M Cristofanilli, J Meisel, KD Miller, Y Abdou, EC Riley, R Qamar, P Sharma, S Reid, N Sinclair, M Faggen, CC Block, N Ko, AH Partridge, WY Chen, M DeMeo, V Attaya, A Okpoebo, J Alberti, Y Liu, E Gauthier, HJ Burstein, MM Regan, SM Tolaney	21/03/2024
Correlation of HER2 Protein Level With mRNA Level Quantified by RNAscope in Breast Cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc	X Li, JH Lee, Y Gao, J Zhang, KM Bates, DL Rimm, H Zhang, GH Smith, D Lawson, J Meisel, J Chang, L Huo	01/02/2024
Improving palbociclib adherence among women with metastatic breast cancer using a CONnected CUstomized Treatment Platform: A pilot study. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners	G Sadigh, JL Meisel, K Byers, A Robles, L Serrano, OS Jung, D Coleman, KA Yeager, I Graetz	01/12/2023
Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	G Pfeiler, D Hlauschek, EL Mayer, C Deutschmann, S Kacerovsky-Strobl, M Martin, JL Meisel, N Zdenkowski, S Loibl, M Balic, H Park, A Prat, C Isaacs, E Bajetta, JM Balko, M Bellet-Ezquerra, J Bliss, H Burstein, F Cardoso, H Fohler, T Foukakis, KA Gelmon, M Goetz, TC Haddad, H Iwata, J Jassem, SC Lee, B Linderholm, M Los, EP Mamounas, KD Miller, PG Morris, E Munzone, EN Gal-Yam, A Ring, L Shepherd, C Singer, C Thomssen, LM Tseng, P Valagussa, EP Winer, AC Wolff, G Zoppoli, J Machacek-Link, C Schurmans, X Huang, E Gauthier, C Fesl, AC Dueck, A DeMichele, M Gnant	20/11/2023
Using Oncotype DX breast recurrence score® assay to define the role of neoadjuvant endocrine therapy in early-stage hormone receptor-positive breast cancer. Breast cancer research and treatment	C Taylor, J Meisel, AJ Foreman, C Russell, D Bandyopadhyay, X Deng, L Floyd, A Zelnak, H Bear, R O'Regan	01/05/2023
Percutaneous CT-Guided Cryoneurolysis of the Intercostobrachial Nerve for Management of Postmastectomy Pain Syndrome. Journal of vascular and interventional radiology : JVIR	N Nezami, A Behi, S Manyapu, JL Meisel, N Resnick, D Corn, JD Prologo	01/05/2023
A Discordant Pattern of Uptake on 68 Ga-PSMA PET/CT Versus 18 F-Fluciclovine PET/CT in Radiation-Induced Hepatitis : Implications for Early Postradiotherapy Imaging-Based Response Assessment. Clinical nuclear medicine	OA Adediran, IO Lawal, S Muzahir, MA Bhave, S Friend, B Fielder, J Meisel, MA Torres, TM Styblo, C Graham, A Holbrook, K Kalinsky, RJ Crowe, GA Ulaner, DM Schuster	01/04/2023
Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management. Gynecologic oncology	YL Liu, BL Manning-Geist, A Knezevic, L Deng, M Bromberg, SA Funt, JL Meisel, O Zivanovic, KL Roche, Y Sonoda, GJ Gardner, RN Grisham, RE O'Cearbhaill, WP Tew, NR Abu-Rustum, DS Chi, C Aghajanian, DR Feldman	01/03/2023
When the personal becomes political: The impact of the Dobbs decision on women with cancer. Cancer	JL Meisel, A Harrington, N Whaley, W Vitek, RM O'Regan	15/01/2023
A Tale of 3 Tracers: Contrasting Uptake Patterns of 18F-Fluciclovine, 68Ga-PSMA, and 18F-FDG in the Uterus and Adnexa. Clinical nuclear medicine	IO Lawal, OA Adediran, S Muzahir, S Friend, MA Bhave, J Meisel, MA Torres, TM Styblo, C Graham, A Holbrook, K Kalinsky, B Fielder, RJ Crowe, GA Ulaner, DM Schuster	01/01/2023
Study Protocol: Efficacy and Safety of Radioembolization (REM) as an Early Modality (EM) Therapy for Metastatic Breast Cancer (BR) to the Liver with Y90 (REMEMBR Y90). Cardiovascular and interventional radiology	R Wu, K Gogineni, J Meisel, S Szabo, M Thirunavu, S Friend, Z Bercu, I Sethi, N Natarajan, J Switchenko, J Levy, E Abdalla, L Weakland, K Kalinsky, N Kokabi	01/11/2022
Recurrent uterine inflammatory myofibroblastic tumor previously managed as leiomyosarcoma has sustained response to alectinib. Gynecologic oncology reports	EV Carballo, TV Pham, G Turashvili, K Hanley, KD Starbuck, JL Meisel	01/10/2022
Evaluating the Effectiveness of a Telehealth Cancer Genetics Program: A BRCA Pilot Study. Public health genomics	E Rose, MW Hardy, R Gates, C Stanislaw, J Meisel, KA Grinzaid	09/08/2022
Utility of Oncotype DX score in clinical management for T1 estrogen receptor positive, HER2 negative, and lymph node negative breast cancer. Breast cancer research and treatment	TTA Nguyen, LM Postlewait, C Zhang, JL Meisel, R O'Regan, S Badve, K Kalinsky, X Li	01/04/2022
Pilot Feasibility Study of a Video Intervention to Educate Patients with Breast Cancer About Clinical Trials. Journal of cancer education : the official journal of the American Association for Cancer Education	KA Yeager, J Bai, K Gogineni, JL Meisel, J Kweon, DW Bruner, D Waldrop-Valverde	01/04/2022
Correlates of financial toxicity in adult cancer patients and their informal caregivers. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer	G Sadigh, J Switchenko, KE Weaver, D Elchoufi, J Meisel, MA Bilen, D Lawson, D Cella, B El-Rayes, R Carlos	01/01/2022
Are we closer to being able to select patients with node-positive hormone receptor-positive breast cancer who can safely omit chemotherapy? Therapeutic advances in medical oncology	C Taylor, J Meisel, K Kalinsky	01/01/2022
Molecular Classification of Triple Negative Breast Cancer and the Emergence of Targeted Therapies. Clinical breast cancer	E Sakach, R O'Regan, J Meisel, X Li	01/12/2021
Case report of lymph node activation mimicking cancer progression: A false positive F¹⁸ FDG PET CT after COVID-19 vaccination. Current problems in cancer. Case reports	R Schapiro, VM Moncayo, JL Meisel	01/12/2021
Folate Receptor Alpha Is Preferentially Expressed in the Carcinoma Component of Endometrial Carcinosarcomas: A Potential Target for Adjuvant Therapy. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists	KZ Hanley, IR Horowitz, A Gordon, J Meisel, N Khanna	01/09/2021
We have to talk about it: Bringing fertility into the conversation for young women with breast cancer. Cancer	CE Taylor, JL Meisel	15/08/2021
Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	SM Smith, K Wachter, HA Burris, RL Schilsky, DJ George, DE Peterson, ML Johnson, MJ Markham, KF Mileham, MS Beg, JC Bendell, R Dreicer, VL Keedy, RJ Kimple, MA Knoll, N LoConte, H MacKay, JL Meisel, TJ Moynihan, DA Mulrooney, TM Mulvey, O Odenike, NA Pennell, K Reeder-Hayes, C Smith, RJ Sullivan, R Uzzo	01/04/2021
Weighing the influence of race and obesity on outcomes in patients with early-stage breast cancer. Cancer	CE Taylor, JL Meisel	15/03/2021
The Influence of Histologic Grade on Outcomes of Elderly Women With Early Stage Breast Cancer Treated With Breast Conserving Surgery With or Without Radiotherapy. Clinical breast cancer	CE Escott, D Zaenger, JM Switchencko, JY Lin, M Abugideiri, CA Arciero, NT Pfister, KM Xu, JL Meisel, P Subhedar, M Torres, WJ Curran, PR Patel	01/12/2020
HER2 immunohistochemistry staining positivity is strongly predictive of tumor response to neoadjuvant chemotherapy in HER2 positive breast cancer. Pathology, research and practice	J Zhao, U Krishnamurti, C Zhang, J Meisel, Z Wei, A Suo, R Aneja, Z Li, X Li	01/11/2020
Evaluation of PD-L1, tumor-infiltrating lymphocytes, and CD8+ and FOXP3+ immune cells in HER2-positive breast cancer treated with neoadjuvant therapies. Breast cancer research and treatment	J Zhao, J Meisel, Y Guo, R Nahta, KL Hsieh, L Peng, Z Wei, R O'Regan, X Li	01/10/2020
The Impact of Genetic Counseling Educational Tools on Patients' Knowledge of Molecular Testing Terminology. Journal of cancer education : the official journal of the American Association for Cancer Education	BA McDaniels, RS Hianik, C Bellcross, WL Shaib, J Switchenko, MD Dixon, JL Meisel, K Gogineni, RD Pentz	01/10/2020
Optimizing the Duration of Trastuzumab: A Fresh Perspective. Oncology (Williston Park, N.Y.)	MA Taylor, KF Byers, JL Meisel	12/08/2020
Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	MJ Markham, K Wachter, N Agarwal, MM Bertagnolli, SM Chang, W Dale, CSM Diefenbach, C Rodriguez-Galindo, DJ George, TD Gilligan, RD Harvey, ML Johnson, RJ Kimple, MA Knoll, N LoConte, RG Maki, JL Meisel, JA Meyerhardt, NA Pennell, GB Rocque, MS Sabel, RL Schilsky, BJ Schneider, WD Tap, RG Uzzo, SN Westin	01/04/2020
Clinicopathologic Factors Associated With Response to Neoadjuvant Anti-HER2-Directed Chemotherapy in HER2-Positive Breast Cancer. Clinical breast cancer	JL Meisel, J Zhao, A Suo, C Zhang, Z Wei, C Taylor, R Aneja, U Krishnamurti, Z Li, R Nahta, R O'Regan, X Li	01/02/2020
Race, breast cancer, and prognosis: Where biology is queen? Cancer	JL Meisel, RM O'Regan	15/09/2019
A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study). Breast cancer research : BCR	TA Patel, JE Ensor, SL Creamer, T Boone, AA Rodriguez, PA Niravath, JG Darcourt, JL Meisel, X Li, J Zhao, JG Kuhn, RR Rosato, W Qian, A Belcheva, MR Schwartz, VG Kaklamani, JC Chang	02/09/2019
A Big World Made Small: Using Social Media to Optimize Patient Care. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting	IM Subbiah, E Hamilton, M Knoll, K Shanahan, J Meisel	01/01/2019
Breast Cancer and Heart Failure. Heart failure clinics	Z Almuwaqqat, JL Meisel, A Barac, S Parashar	01/01/2019
Evaluation of Prognosis in Hormone Receptor-Positive/HER2-Negative and Lymph Node-Negative Breast Cancer With Low Oncotype DX Recurrence Score. Clinical breast cancer	J Meisel, C Zhang, C Neely, P Mendoza, S You, T Han, Y Liu, AA Sahin, R O'Regan, X Li	01/10/2018
Validation of the newly proposed American Joint Committee on Cancer (AJCC) breast cancer prognostic staging group and proposing a new staging system using the National Cancer Database. Breast cancer research and treatment	X Li, Y Zhang, J Meisel, R Jiang, M Behera, L Peng	01/09/2018
Multidisciplinary Approaches to Chest Wall Recurrences of Breast Cancer. Oncology (Williston Park, N.Y.)	C Arciero, P Thompson, JL Meisel, CE Taylor, MA Torres, WC Wood	15/08/2018
Evolution of Targeted Therapy in Breast Cancer: Where Precision Medicine Began. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting	JL Meisel, VA Venur, M Gnant, L Carey	23/05/2018
Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research	B Weigelt, I Comino-Méndez, I de Bruijn, L Tian, JL Meisel, I García-Murillas, C Fribbens, R Cutts, LG Martelotto, CKY Ng, RS Lim, P Selenica, S Piscuoglio, C Aghajanian, L Norton, R Murali, DM Hyman, L Borsu, ME Arcila, J Konner, JS Reis-Filho, RA Greenberg, ME Robson, NC Turner	01/11/2017
Management of Breast Cancer Therapy-Related Sexual Dysfunction. Oncology (Williston Park, N.Y.)	CE Taylor, JL Meisel	15/10/2017
Wilms' tumor of the ovary. Gynecologic oncology reports	VM Alexander, J Meisel, S O'Brien, N Khanna	01/02/2017
For Our Patients, for Ourselves: The Value of Personal Reflection in Oncology. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting	L Schapira, JL Meisel, R Srivastava	01/01/2017
Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer. Breast cancer research and treatment	X Li, J Yang, L Peng, AA Sahin, L Huo, KC Ward, R O'Regan, MA Torres, JL Meisel	01/01/2017
Prevention and Screening in Hereditary Breast and Ovarian Cancer. Oncology (Williston Park, N.Y.)	SB Zeichner, C Stanislaw, JL Meisel	15/10/2016
Stromal PD-L1 Expression Is Associated With Better Disease-Free Survival in Triple-Negative Breast Cancer. American journal of clinical pathology	X Li, CS Wetherilt, U Krishnamurti, J Yang, Y Ma, TM Styblo, JL Meisel, L Peng, MT Siddiqui, C Cohen, R Aneja	01/10/2016
Development of a risk stratification system to guide treatment for female germ cell tumors. Gynecologic oncology	JL Meisel, KM Woo, N Sudarsan, J Eng, S Patil, EP Jacobsen, R Murali, GJ Gardner, GJ Bosl, C Aghajanian, DR Feldman	01/09/2015

Awards

Dr. Meisel has received several teaching awards, including the Resident Mentor Award and Notable Teaching Award at Brigham and Women's Hospital. She currently serves as a core faculty member for the internal medicine residency at Emory University School of Medicine where she enjoys mentoring students and residents in the clinic and in their research.

She received an American Society for Clinical Oncology (ASCO) Young Investigator Award in 2014 for her research evaluating the use of circulating tumor DNA to detect platinum resistance in patients with BRCA mutations and recurrent ovarian cancer.

She has been consistently listed in Atlanta Magazine's annual "Top Doctors" issue.

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.

5	One star One star One star One star One star	Provider showed concern
4.9	One star One star One star One star One half star	Provider explained things clearly
4.9	One star One star One star One star One half star	Provider discussed treatment options
5	One star One star One star One star One star	Provider included you in decisions
5	One star One star One star One star One star	Likelihood of recommending this provider

View Reviews


One star One star One star One star One star	06/05/2024	Dr Jane Meisel is an exemplary health care provider. She's awesome!
One star One star One star One star One star	04/05/2024	Dr Jane is best cancer Dr explained every thinh
One star One star One star One star One star	01/05/2024	Drs Woods and Meisel were excellent as always. Listened to my concerns and questions and responded accordingly. Love their friendly, professional, courteous bedside manner and treatment.
One star One star One star One star One star	01/05/2024	I was scared for by a Fellow then Dr Meisel. Both were very good about explaining my issues and answering questions.
One star One star One star One star One star	24/04/2024	Dr. Meisel is THE BEST!! EHC is lucky to have her!!!
One star One star One star One star One star	20/04/2024	Dr Meisel was very informed about my case due to her reviews and collaboration with both my surgeon and radiation oncologist. I am very pleased that the physicians at Emory Winship work as a team to determine my care plan!
One star One star One star One star One star	05/04/2024	Dr. Meisel is very thorough, professional, and empathetic.
One star One star One star One star One star	30/03/2024	I just can't say enough good things about Dr Meisel. Just know that she's just so human and caring. She's more than a good Dr. She's a kind and compassionate human being.
One star One star One star One star One star	29/03/2024	She is simply the best.
One star One star One star One star One star	15/03/2024	Provider was wonderful answered all my questions.
One star One star One star One star One star	13/03/2024	Dr Meise was amazing. She went over several options for future treatments, listened to my concerns and was very well informed with my situation before my appointment
One star One star One star One star One star	07/03/2024	She was perfect!
One star One star One star One star One star	07/03/2024	Dr Meisel was wonderful and took the time to really discuss my concerns and questions.
One star One star One star One star One half star	06/03/2024	Dr. Meisel is the best!!
One star One star One star One star One star	24/02/2024	Excellent
One star One star One star One star One star	20/02/2024	The BEST
One star One star One star One star One star	20/02/2024	Dr. Meizel is clearly an asset to Emory!!!
One star One star One star One star One star	31/01/2024	I LOVE DR. MEISEL. I stared this cancer journey with her & every step of the way she has been AMAZING. Especially going through cancer. She & her staff are EXCELLENT. I knew IMMEDIATELY that moving back here there's NO oncologist I would have wanted to be responsible for my care.
One star One star One star One star One star	13/01/2024	I love my experiences with my doctors and Emory I tells people here how much I love the hospital and the care.
One star One star One star One star One star	13/01/2024	Dr. Meisel is by far the best oncologist I have seen since I was diagnosed 26 years ago. She always takes time to answer any concerns that I may have. She is personable, organized, and detail-oriented and shows a genuine concern for her patients.
One star One star One star One star One star	12/01/2024	Dr. Meisel is one of the best doctors I have ever had the privilege of seeing. She is so knowledgeable, professional, and kind. She shows how much she cares about her patients' welfare. I trust her completely. I know that I am getting the best care possible at Emory, and Dr. Meisel is certainly a big reason for that.
One star One star One star One star One half star	10/01/2024	Dr. Meisel seems well prepared to guide my wife's complex care. She inspires confidence.
One star One star One star One star One star	08/01/2024	Dr Meisel is amazing. Smart, attentive, comforting. She is great!
One star One star One star One star One star	06/01/2024	Dr. Meisel is very patient and always answers all of my questions thoroughly. She's a pleasure.
One star One star One star One star One star	21/12/2023	Dr Meisel is simply the best. I always have many questions and she is there to answer them. I am a part of the planning. We are a partnership! Thank you for your support and caring through a rough patch this summer and fall.
One star One star One star One star One star	20/12/2023	I received thorough information about future treatments, medications and visits
One star One star One star One star One star	19/11/2023	I never stop being impressed by the level of excellence I am treated with at Emory, particularly my experiences with Dr. Jane Meisel
One star One star One star One star One star	18/11/2023	Dr. Meisel is always very sensitive and understanding. She went out of her way to enable me to keep my appointment via video since I did not feel comfortable coming in with a cold.
One star One star One star One star One star	08/11/2023	Very good
One star One star One star One star One star	25/10/2023	Dr Meisel is just a good Dr. She has been from day one. She's knowledgeable about her work, she's kind and compassionate. She treats me like I am family. I think I would have given up by now but for her. I wish more doctors were like her. Kindness and compassion goes a long way with cancer patients.
One star One star One star One star One star	04/10/2023	I would and have recommended Dr. Miesel to everyone going through a cancer diagnosis and treatment. Her team is also excellent
One star One star One star One star One star	30/09/2023	Dr Price (assistant in training) was courteous and well versed on my medical history. Dr Meisel was superb, as always.knowledgeable and trustworthy!
One star One star One star One star One star	13/09/2023	Dr Meisel is extraordinary & a gem
One star One star One star One star One star	09/09/2023	The whole visit was very helpful .
One star One star One star One star One star	28/08/2023	The ease in explaining my options as well as the clinical research that undergirds these options was excellent.
One star One star One star One star One star	24/08/2023	Dr Miesel has been very professional, caring and a great listener. She doesn't mind going the extra mile to get information or whatever is helpful or needed for me as her patient. She is the type of physician all patients should have.
One star One star One star One star One star	23/08/2023	Dr Jane Meisel is an excellent physician
One star One star One star One star One star	22/08/2023	Dr. Was amazing! Very knowledgeable!
One star One star One star One star One star	16/08/2023	Very informative excellent from start to finish
One star One star One star One star One star	02/08/2023	I came for a second opinion and Dr. Meisel was very prepared to talk with me and gave me some additional steps to take/ valuable recommendations
One star One star One star One star One star	29/07/2023	Dr.Meisel was great !!!
One star One star One star One star One star	18/07/2023	Dr Meisel was amazing
One star One star One star One star One star	08/07/2023	My Minnesota oncologist referred me to Dr. Meisel, and she was wonderful.
One star One star One star One star One star	08/07/2023	Excellent
One star One star One star One star One star	05/07/2023	Dr. Meisel was excellent. She listened to me and offered what I thought was sound advice. She also allayed any fears I had about treatment options. I will highly recommend her!
One star One star One star One star One star	28/06/2023	Dr Meisel takes care of me and I would recommend her to anyone I know. I've only seen her Assistance once she was nice professional. The staff In the chemo lab are all kind and professional. I wish I had been assigned to someone like Dr Meisel as caring and In tune with her patients rather than the surgeon zDr Stybilo.
One star One star One star One star One star	28/06/2023	I would recommend Dr. Miezel she is the best. She listen to your concerns and she is there on portal.
One star One star One star One star One star	28/06/2023	Dr. Meisel is always very professional but also empathetic. She is extremely thorough and never seems hurried. I consider myself very lucky to have her for my doctor .
One star One star One star One star One star	27/06/2023	Dr. Meisel is the consummate physician who addresses my care as if I were a member of her family.
One star One star One star One star One star	20/06/2023	Dr Meisel was prepared for the visit and knew the details of my case when she walked into the exam room. This was awesome.
One star One star One star One star One star	14/06/2023	Dr. Meisel was very helpful in explaining some lab results.
One star One star One star One star One star	31/05/2023	Dr Meisel is excellent!!
One star One star One star One star One star	27/05/2023	Dr Meisel, always excellent!
One star One star One star One star One star	20/05/2023	Dr Meisel was amazing and used the word "cure" which I needed to hearShe was easy to talk with and I left with a very positive feeling
One star One star One star One star One star	17/05/2023	I appreciate the time spend with me and felt that I received excellent care.
One star One star One star One star One star	10/05/2023	Dr. Meisel takes whatever time is necessary to give me complete patient care and attention.
One star One star One star One star One star	06/05/2023	Excellent
One star One star One star One star One star	02/05/2023	Dr. Meisel is a super star of a person,a great and caring physician.
One star One star One star One star One star	21/04/2023	Dr. Meisel made the effort to contact me via phone to set up an optional Zoom visit when the MyChart virtual platform didn't connect us. This was after I had waited about an hour. I was so appreciative of her doing that. The appointment was able to take place and all went well.
One star One star One star One star One star	01/04/2023	Dr. Meisel is the best medical oncologist that I have encountered in my 26 years as a cancer patient, and I have had quite a few in four different cities. Her knowledge, coupled with compassion, is a rarity in the medical field.
One star One star One star One star One star	22/03/2023	She was very professional and easy to communicate with.
One star One star One star One star One star	08/03/2023	Dr. Meisel worked me into her schedule with a teleconference giving us the ability for a consult a month earlier that planned.
One star One star One star One star One star	19/02/2023	Dr Meisel is simply the best, she's human first.She takes the time to listen and suggest depending on the diagnosis.
One star One star One star One star One star	26/09/2022	Dr Meisel and staff were very friendly and provided me with an exceptional experience. Thank you for being so compassionate Dr Meisel
One star One star One star One star One star	21/09/2022	Wonderful, informative, caring and inclusive appointment, seriously considering my thoughts and concerns.
One star One star One star One star Empty star	20/09/2022	Would have liked to have had my scan and lab results up front so I could better follow the discussion of my new results and be able to ask better questions.
One star One star One star One star One star	19/09/2022	Dr. Meisel never makes me feel rushed and cares that I understand everything
One star One star One star One star One star	12/09/2022	Awesome awesome awesome care team.
One star One star One star One star One star	05/09/2022	Jane Meisel is an excellent doctor!
One star One star One star One star One star	02/09/2022	Absolutely excellent all around!
One star One star One star One star One star	27/08/2022	Dr Meisel was awesome
One star One star One star One star One star	15/08/2022	Dr. Meisel is a great doctor and her staff is always pleasant and caring. She keeps me informed and shows concern for my mother.
One star One star One star One star One star	14/08/2022	Excellent
One star One star One star One star One star	09/08/2022	Dr. Maisel took all the time we needed and answered all questions. She was very thorough, attentive and caring.
One star One star One star One star One star	08/08/2022	Jane is the best! Her support and caring mean so much to me.
One star One star One star One star One star	07/08/2022	Very pleased with Dr. Jane Meisel and her staff. Also call center is very responsive and courteous.
One star One star One star One star One star	06/08/2022	Dr Meisel is amazing!! Super caring and attentive with a great positive attitude!!
One star One star One star One star One star	14/07/2022	Dr. Meisel is great! I really appreciated her taking the time to fit me in. She answered all my questions and was kind and smart. I mainly needed a second opinion, as Emory is a bit far from my house, and she provided this opinion and also made it clear that she was available if I needed her at any time. I really like this doctor and will definitely be in contact as I navigate my treatment over the next 6-12 months.
One star One star One star One star One star	30/06/2022	Dr. Meisel is an excellent and caring physician. I have great confidence in her which is critically important in the healing process.
One star One star One star One star One star	29/06/2022	Dr. Meisel always listens to my concerns even if they are unique to me. I have great anxiety about taking medication and she is so patient and attentive and always willing to meet me where I am at.
One star One star One star One star One star	27/06/2022	I think Dr. Meisel is one of the most caring and compassionate doctors I know and I truly appreciate that she discusses options and the plan.
One star One star One star One star One star	25/06/2022	I have been a patient of Dr. Meisel Since 2015 and I still consider her to be one of the best doctors at Emory. And her staff is equally wonderful.
One star One star One star One star One star	24/06/2022	Dr. Meisel was outstanding as usual - kind, compassionate, thorough in her exam, and clear at explaining the latest research applicable to my care in concise, practical terms. She is also extremely personable and has such poise/grace. I am so glad she Is my oncologist!
One star One star One star One star One star	23/06/2022	I'm very grateful Dr Meisel is my oncologist! She is extremely competent, caring and professional! I wish all doctors treated patients as she does!
One star One star One star One star One star	23/06/2022	Dr. Meisel Always allows me to be a part of my own healthcare team! She understands how some things like medications & care can/does effect my mental health & I'm in a great place because of her. I'm so lucky to have her as my oncologist.
One star One star One star One star One star	22/06/2022	Dr. Meisel listened and responded to my concerns in a positive manner.
One star One star One star One star One star	19/06/2022	Good experience with all my dr.'s at Emory.
One star One star One half star Empty star Empty star	19/06/2022	See previous comments. She was super sweet and caring, but seemed overwhelmed and confused, and obviously did not know much about my case. It is hard to have confidence in her when she was asking if a medication was OTC or prescription.
One star One star One star One star One star	16/06/2022	Always look forward to my visits with Dr. Miesel!
One star One star One star One star One star	08/06/2022	She is amazing!
One star One star One star One star One star	08/06/2022	Primary provider of care was Dr Meisel
One star One star One star One star One star	01/06/2022	Very good isn't good enough. Dr. Meisel is excellent!!
One star One star One star One star One star	28/05/2022	I have recommended already - care and attention is excellent
One star One star One star One star One star	28/05/2022	I am always confident that my PCP will be briefed and consulted, as appropriate, in my treatment plan.